Republicans pass tax bill and repeal the Affordable Care Act's individual mandate; potential healthcare mergers and deals pick up in December; millions of dollars paid out to combat the national conversation around rising drug prices.
Both the House and the Senate passed the Republican tax bill with 12 House Republicans voting against the bill and all Senate Republicans present voting in favor—no Democrats voted for the bill. According to The New York Times, the bill reaches far beyond taxes and will eliminate the Affordable Care Act’s individual mandate. Since the Senate had to slightly change the bill in order to pass it with just 50 votes, the House will have to vote on it again. The Congressional Budget Office estimates that repealing the individual mandate could result in 13 million fewer Americans having health insurance by 2027.
As the end of the year grows closer, the number of business deals in healthcare is increasing. The cumulative revenue of companies involved in potential deals announced in December is more than $550 billion, reported The Wall Street Journal. Humana and 2 private-equity firms announced they will buy Kindred Healthcare for $810 million. Tenet Healthcare is considering selling Conifer Health Solutions. Plus, Ascension and Providence St. Joseph Health are in talks, as are Dignity Health and Catholic Health Initiatives. The deals highlight the need among healthcare companies to drive down costs and change where care is delivered to patients.
Millions of dollars have been paid out to lobbyists, politicians, and patient groups to battle the national conversation around rising drug prices. Kaiser Health News reported that the Pharmaceutical Research and Manufacturers of America, aka PhRMA, spent $7 million on a campaign to steer the conversation away from prices and remind people of the groundbreaking work being done to beat diseases. PhRMA also gave big checks to patient groups like the American Lung Association and the Lupus Foundation of America. Both the Republican Governors Association and the Democratic Governors Association received more than $300,000.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More